Company record
NeuroSync, Inc.
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about NeuroSync, Inc..
Warning letters
-
DevicesNeuroSync, Inc.
FDA warned NeuroSync, Inc. that its EYE-SYNC eye-assessment device was adulterated by design control, CAPA, supplier and acceptance failures, plus unreported correction and missing UDI.
High risk